Inhibikase Therapeutics IKT Q1 2026 Earnings Narrowing Losses as Pipeline Progress Takes Center Stage AEVA Q1 2026 Earnings EPS Beat Drives Significant Stock Rally ULCC Q1 2026 Earnings WiderThanExpected Loss Narrows Shares Surge 7 Rapid7 Q1 2026 Earnings EPS Surprise Drives Positive Market Response Immunovant Q1 2026 Earnings Wider Than Expected Loss Amid No Revenue BKR Q1 2026 Earnings Strong EPS Beat of 1616 Driven by Operational Efficiency